摘要
本研究改进了依托度酸(1)的合成工艺。以邻乙基溴苯(3)为起始原料,经水合肼肼解后成盐精制制得邻乙基苯肼盐酸盐(4),4在碱性条件下游离后经Amberlyst 15树脂催化与2,3-二氢呋喃(5)反应生成7-乙基色醇(2),2不经分离与3-氧代戊酸甲酯(6)缩合环化得依托度酸甲酯(7),最后水解制得目标产品1,纯度99.91%,总收率68%(以5计)。其中由3制备2的方法未见文献报道,改进后的工艺操作简便,缩短了生产周期,已经公斤级放大验证,适合工业化生产。
The synthetic process of etodolac(1)was improved.o-Ethyl phenylhydrazine hydrochloride(4)was obtained from o-ethyl bromobenzene(3)by hydrazinolysis of hydrazine hydrate and salification,and then free 4 in alkaline condition reacted with 2,3-dihydrofuran(5)on exposure to Amberlyst 15 ion-exchange resin to afford 7-ethyltryptophol(2).Without separation,2 was condensed with methyl 3-oxovanoate(6)to obtain methyl etodolate(7),and followed by hydrolysis to get the target compound 1 with a total yield of 68%(based on 5)and a purity of 99.91%.The synthetic method for 2 from 3 has not yet been found in literature.The optimized process had simple operation,and shortened production cycle,which has been verified by kilogram scale-up and was suitable for industrial production.
作者
张乃华
鲍广龙
聂建兵
王伟
张贵民
ZHANG Naihua;BAO Guanglong;NIE Jianbing;WANG Wei;ZHANG Guimin(National Engineering and Technology Research Center of Chirality Pharmaceutical,Shandong New Time Pharmaceutical Co.,Ltd.,Linyi 273400)
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2021年第4期495-498,共4页
Chinese Journal of Pharmaceuticals
关键词
依托度酸
非甾体抗炎药
合成工艺
etodolac
non-steroid anti-inflammatory drug
synthetic process
